Journal
HAEMATOLOGICA
Volume 101, Issue 10, Pages 1170-1179Publisher
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2016.146316
Keywords
-
Categories
Funding
- British Heart Foundation [RG/PG/13/36/30275, RG/09/007]
- MRC
- Wellcome Trust [093994]
- Healing Foundation
- Platelet Charity
- Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre Award to Guy's & St Thomas' NHS Foundation Trust
- King's College London
- King's College Hospital NHS Foundation Trust
- Queen Elizabeth Hospital Charity
- British Heart Foundation [PG/13/36/30275, FS/13/70/30521, FS/11/49/28751] Funding Source: researchfish
Ask authors/readers for more resources
Inherited thrombocytopenias are a heterogeneous group of disorders characterized by abnormally low platelet counts which can be associated with abnormal bleeding. Next-generation sequencing has previously been employed in these disorders for the confirmation of suspected genetic abnormalities, and more recently in the discovery of novel disease-causing genes. However its full potential has not yet been exploited. Over the past 6 years we have sequenced the exomes from 55 patients, including 37 index cases and 18 additional family members, all of whom were recruited to the UK Genotyping and Phenotyping of Platelets study. All patients had inherited or sustained thrombocytopenia of unknown etiology with platelet counts varying from 11x10(9)/L to 186x10(9)/L. Of the 51 patients phenotypically tested, 37 (73%), had an additional secondary qualitative platelet defect. Using whole exome sequencing analysis we have identified pathogenic or likely pathogenic variants in 46% (17/37) of our index patients with thrombocytopenia. In addition, we report variants of uncertain significance in 12 index cases, including novel candidate genetic variants in previously unreported genes in four index cases. These results demonstrate that whole exome sequencing is an efficient method for elucidating potential pathogenic genetic variants in inherited thrombocytopenia. Whole exome sequencing also has the added benefit of discovering potentially pathogenic genetic variants for further study in novel genes not previously implicated in inherited thrombocytopenia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available